New Clinical Research Suggests GLP1 Medications Significantly Improve Recovery Outcomes After Serious Heart Attacks
A groundbreaking medical study has unveiled that the class of drugs originally designed to treat type 2 diabetes and obesity may hold the key to a more robust recovery for cardiac patients.
